HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Graybug Vision, Inc. (GRAY)
5.05  -0.69  (-12.02%) 06-21 02:42
Open: 5.3942 High: 5.67
Pre.close: 5.74 Low: 5
Volume: 2,201,657 Ave vol: 1,891,992
52w High: 37.88 52w Low: 3.43
MA(50): 4.33 MA(200): 15.156
EPS: P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.graybug.vision
Market Cap (M): 106
Shares Out (M): 21
Graybug Vision, Inc., a clinical stage biopharmaceutical company, develops medicines for the treatment of diseases of the retina and optic nerve. Its lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. The company is also developing GB-103, a once-a-year formulation of GB-102, for the treatment of diabetic retinopathy; and GB-401, a depot formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was founded in 2011 and is based in Redwood City, California.
Technical analysis
Overall: Underperform
MA: Bearish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 6.56 Target 2: 8.14
Resist 1: 5.62 Resist 2: 6.97
Support 1: 3.43 Support 2: 2.85
Company key metrics
Revenue per Share: 0
Net Income per Share: -9.7685
Cash per Share: 33.7194
Book Value per Share: 33.6317
Price to Sales: 0
Price to Book Value: 0.9113
Earnings Yield: -0.3187
Dividend Yield: 0
Debt to Equity: 0
Debt to Assets: 0.0688
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.